- Business Wire•19 hours agoTeva to Present New Respiratory Data at the 2016 European Respiratory Society (ERS) International Congress
Teva Pharmaceutical Industries Ltd., today announced that five company-sponsored abstracts will be presented at the 2016 European Respiratory Society International Congress in London, England on September 3-7, 2016.
- Investor's Business Daily•yesterday
Bowing to political pressure, Mylan's generics arm will sell a cut-rate version of its own best-selling product.
- Market Realist•yesterday
Analyst recommendations from 17 brokerage firms surveyed by Bloomberg for Akorn (AKRX), 62.5% gave it a “buy,” 37.5% gave it a “hold,” and none gave it a “sell.”
Teva Pharmaceutical Industries Limited (TEVA)
NYSE - NYSE Real Time Price. Currency in USD
|Day's Range||50.38 - 50.95|
|52wk Range||48.01 - 66.55|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||33.77|
|Avg Vol (3m)||5,782,324|
|Dividend & Yield||1.36 (2.64%)|